C. Sarrazin and S. Zeuzem, Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection, Gastroenterology, vol.138, issue.2, pp.447-462, 2010.
DOI : 10.1053/j.gastro.2009.11.055

R. Brown, Hepatitis C and liver transplantation, Nature, vol.77, issue.7053, pp.973-978, 2005.
DOI : 10.1053/jlts.2003.50268

K. Watt, B. Veldt, and M. Charlton, A Practical Guide to the Management of HCV Infection Following Liver Transplantation, American Journal of Transplantation, vol.8, issue.8, pp.1707-1713, 2009.
DOI : 10.1111/j.1600-6143.2009.02702.x

G. Crespo, Z. Marino, M. Navasa, and X. Forns, Viral Hepatitis in Liver Transplantation, Gastroenterology, vol.142, issue.6, pp.1373-1383, 2012.
DOI : 10.1053/j.gastro.2012.02.011

M. Charlton, Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents - A potentially lethal cocktail, Hepatology, vol.38, issue.1, pp.3-5, 2011.
DOI : 10.1002/hep.24470

M. Zeisel, I. Fofana, S. Fafi-kremer, and T. Baumert, Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies, Journal of Hepatology, vol.54, issue.3, pp.566-576, 2011.
DOI : 10.1016/j.jhep.2010.10.014
URL : https://hal.archives-ouvertes.fr/inserm-00701487

M. Zeisel, J. Lupberger, I. Fofana, and T. Baumert, Host-targeting agents for prevention and treatment of chronic hepatitis C ??? Perspectives and challenges, Journal of Hepatology, vol.58, issue.2, pp.375-384, 2013.
DOI : 10.1016/j.jhep.2012.09.022
URL : https://hal.archives-ouvertes.fr/inserm-00741430

S. Fafi-kremer, I. Fofana, E. Soulier, P. Carolla, and P. Meuleman, Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, The Journal of Experimental Medicine, vol.119, issue.9, pp.2019-2031, 2010.
DOI : 10.1073/pnas.0503596102

I. Fofana, S. Krieger, F. Grunert, S. Glauben, and F. Xiao, Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes, Gastroenterology, vol.139, issue.3, pp.953-964, 2010.
DOI : 10.1053/j.gastro.2010.05.073
URL : https://hal.archives-ouvertes.fr/inserm-00741442

J. Timpe, Z. Stamataki, A. Jennings, K. Hu, and M. Farquhar, Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies, Hepatology, vol.7, issue.1, pp.17-24, 2008.
DOI : 10.1002/hep.21959

P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, and F. Falugi, Binding of Hepatitis C Virus to CD81, Science, vol.282, issue.5390, pp.938-941, 1998.
DOI : 10.1126/science.282.5390.938

B. Lindenbach, M. Evans, A. Syder, B. Wolk, and T. Tellinghuisen, Complete Replication of Hepatitis C Virus in Cell Culture, Science, vol.309, issue.5734, pp.623-626, 2005.
DOI : 10.1126/science.1114016

M. Flint, T. Von-hahn, J. Zhang, M. Farquhar, and C. Jones, Diverse CD81 Proteins Support Hepatitis C Virus Infection, Journal of Virology, vol.80, issue.22, pp.11331-11342, 2006.
DOI : 10.1128/JVI.00104-06
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1642177

B. Bartosch, A. Vitelli, C. Granier, C. Goujon, and J. Dubuisson, Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor, Journal of Biological Chemistry, vol.278, issue.43, pp.41624-41630, 2003.
DOI : 10.1074/jbc.M305289200

J. Zhang, G. Randall, A. Higginbottom, P. Monk, and C. Rice, CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection, Journal of Virology, vol.78, issue.3, pp.1448-1455, 2004.
DOI : 10.1128/JVI.78.3.1448-1455.2004

G. Koutsoudakis, E. Herrmann, S. Kallis, R. Bartenschlager, and T. Pietschmann, The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells, Journal of Virology, vol.81, issue.2, pp.588-598, 2007.
DOI : 10.1128/JVI.01534-06

D. Akazawa, T. Date, K. Morikawa, A. Murayama, and M. Miyamoto, CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection, Journal of Virology, vol.81, issue.10, pp.5036-5045, 2007.
DOI : 10.1128/JVI.01573-06

G. Koutsoudakis, A. Kaul, E. Steinmann, S. Kallis, and V. Lohmann, Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses, Journal of Virology, vol.80, issue.11, pp.5308-5320, 2006.
DOI : 10.1128/JVI.02460-05

M. Evans, T. Von-hahn, D. Tscherne, A. Syder, and M. Panis, Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, vol.23, issue.7137, pp.801-805, 2007.
DOI : 10.1038/nature05654

M. Farquhar, K. Hu, H. Harris, C. Davis, and C. Brimacombe, Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis, Journal of Virology, vol.86, issue.8, pp.4305-4316, 2012.
DOI : 10.1128/JVI.06996-11

H. Harris, M. Farquhar, C. Mee, C. Davis, and G. Reynolds, CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry, Journal of Virology, vol.82, issue.10, pp.5007-5020, 2008.
DOI : 10.1128/JVI.02286-07

H. Harris, C. Davis, J. Mullins, K. Hu, and M. Goodall, Claudin Association with CD81 Defines Hepatitis C Virus Entry, Journal of Biological Chemistry, vol.285, issue.27, pp.21092-21102, 2010.
DOI : 10.1074/jbc.M110.104836

M. Farquhar, H. Harris, M. Diskar, S. Jones, and C. Mee, Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity, Journal of Virology, vol.82, issue.17, pp.8797-8811, 2008.
DOI : 10.1128/JVI.00592-08

S. Krieger, M. Zeisel, C. Davis, C. Thumann, and H. Harris, Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations, Hepatology, vol.79, issue.4, pp.1144-1157, 2010.
DOI : 10.1002/hep.23445
URL : https://hal.archives-ouvertes.fr/inserm-00705657

J. Lupberger, M. Zeisel, F. Xiao, C. Thumann, and I. Fofana, EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nature Medicine, vol.31, issue.5, pp.589-595, 2011.
DOI : 10.1016/0022-1759(83)90303-4
URL : https://hal.archives-ouvertes.fr/inserm-00705829

A. Ploss, M. Evans, V. Gaysinskaya, M. Panis, and H. You, Human occludin is a hepatitis C virus entry factor required for infection of mouse cells, Nature, vol.309, issue.7231, pp.882-886, 2009.
DOI : 10.1038/nature07684

M. Dorner, J. Horwitz, J. Robbins, W. Barry, and Q. Feng, A genetically humanized mouse model for hepatitis C virus infection, Nature, vol.49, issue.7350, pp.208-211, 2011.
DOI : 10.1038/nature10168

J. Bitzegeio, D. Bankwitz, K. Hueging, S. Haid, and C. Brohm, Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors, PLoS Pathogens, vol.5, issue.7, p.1000978, 2010.
DOI : 10.1371/journal.ppat.1000978.s008

P. Meuleman, J. Hesselgesser, M. Paulson, T. Vanwolleghem, and I. Desombere, Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo, Hepatology, vol.8, issue.6, pp.1761-1768, 2008.
DOI : 10.1002/hep.22547

T. Wakita, T. Pietschmann, T. Kato, T. Date, and M. Miyamoto, Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.791-796, 2005.
DOI : 10.1002/jmv.10297

J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, and T. Kato, Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.102, issue.26, pp.9294-9299, 2005.
DOI : 10.1073/pnas.0503596102

C. Brimacombe, J. Grove, L. Meredith, K. Hu, and A. Syder, Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission, Journal of Virology, vol.85, issue.1, pp.596-605, 2011.
DOI : 10.1128/JVI.01592-10
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014195

B. Sainz, . Jr, N. Barretto, D. Martin, N. Hiraga et al., Identification of the Niemann-Pick C1???like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor, Nature Medicine, vol.18, issue.2, pp.281-285, 2012.
DOI : 10.1016/S0002-9440(10)63352-4

J. Witteveldt, M. Evans, J. Bitzegeio, G. Koutsoudakis, and A. Owsianka, CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells, Journal of General Virology, vol.90, issue.1, pp.48-58, 2009.
DOI : 10.1099/vir.0.006700-0

C. Jones, M. Catanese, L. Law, S. Khetani, and A. Syder, Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system, Nature Biotechnology, vol.101, issue.2, pp.167-171, 2010.
DOI : 10.1038/nbt.1604

J. Pestka, M. Zeisel, E. Blaser, P. Schurmann, and B. Bartosch, Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.6025-6030, 2007.
DOI : 10.1073/pnas.0607026104
URL : https://hal.archives-ouvertes.fr/inserm-00395910

C. Mee, H. Harris, M. Farquhar, G. Wilson, and G. Reynolds, Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells, Journal of Virology, vol.83, issue.12, pp.6211-6221, 2009.
DOI : 10.1128/JVI.00246-09
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687400

M. Zahid, M. Turek, F. Xiao, D. Thi, V. Guerin et al., The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination, Hepatology, vol.52, issue.2, pp.492-504, 2013.
DOI : 10.1002/hep.26097
URL : https://hal.archives-ouvertes.fr/inserm-00850917

A. Haberstroh, E. Schnober, M. Zeisel, P. Carolla, and H. Barth, Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion, Gastroenterology, vol.135, issue.5, pp.1719-1728, 2008.
DOI : 10.1053/j.gastro.2008.07.018

D. Costa, D. Turek, M. Felmlee, D. Girardi, E. Pfeffer et al., Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells, Journal of Virology, vol.86, issue.21, pp.11919-11925, 2012.
DOI : 10.1128/JVI.01066-12
URL : https://hal.archives-ouvertes.fr/inserm-00734834

B. Bartosch, J. Dubuisson, and F. Cosset, Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003.
DOI : 10.1093/emboj/21.12.2893
URL : https://hal.archives-ouvertes.fr/inserm-00133783

H. Zhu, F. Wong-staal, H. Lee, A. Syder, and J. Mckelvy, Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals, Journal of Infectious Diseases, vol.205, issue.4, pp.656-662, 2012.
DOI : 10.1093/infdis/jir802

L. Zhao, M. Wientjes, and J. Au, Evaluation of Combination Chemotherapy: Integration of Nonlinear Regression, Curve Shift, Isobologram, and Combination Index Analyses, Clinical Cancer Research, vol.10, issue.23, pp.7994-8004, 2004.
DOI : 10.1158/1078-0432.CCR-04-1087

C. Bertaux and T. Dragic, Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry, Journal of Virology, vol.80, issue.10, pp.4940-4948, 2006.
DOI : 10.1128/JVI.80.10.4940-4948.2006

M. Zeisel, G. Koutsoudakis, E. Schnober, A. Haberstroh, and H. Blum, Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.279, issue.6, pp.1722-1731, 2007.
DOI : 10.1002/hep.21994
URL : https://hal.archives-ouvertes.fr/inserm-00395706

I. Fofana, S. Fafi-kremer, P. Carolla, C. Fauvelle, and M. Zahid, Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies, Gastroenterology, vol.143, issue.1, pp.223-233, 2012.
DOI : 10.1053/j.gastro.2012.04.006
URL : https://hal.archives-ouvertes.fr/inserm-00701511

J. Boyle, A. Silva, J. Brady, and A. Lew, DNA immunization: Induction of higher avidity antibody and effect of route on T cell cytotoxicity, Proceedings of the National Academy of Sciences, vol.94, issue.26, pp.14626-14631, 1997.
DOI : 10.1073/pnas.94.26.14626

M. Flint, C. Maidens, L. Loomis-price, C. Shotton, and J. Dubuisson, Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor CD81, J Virol, vol.73, pp.6235-6244, 1999.

A. Owsianka, R. Clayton, L. Loomis-price, J. Mckeating, and A. Patel, Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2, Journal of General Virology, vol.82, issue.8, pp.1877-1883, 2001.
DOI : 10.1099/0022-1317-82-8-1877

A. Patel, J. Wood, F. Penin, J. Dubuisson, and J. Mckeating, Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding, Journal of General Virology, vol.81, issue.12, pp.2873-2883, 2000.
DOI : 10.1099/0022-1317-81-12-2873
URL : https://hal.archives-ouvertes.fr/hal-00313709

A. Schwarz, J. Grove, K. Hu, C. Mee, and P. Balfe, Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization, Journal of Virology, vol.83, issue.23, pp.12407-12414, 2009.
DOI : 10.1128/JVI.01552-09

P. Meuleman, M. Catanese, L. Verhoye, I. Desombere, and A. Farhoudi, A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo, Hepatology, vol.17, issue.2, pp.364-372, 2012.
DOI : 10.1002/hep.24692

K. Lacek, K. Vercauteren, K. Grzyb, M. Naddeo, and L. Verhoye, Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice, Journal of Hepatology, vol.57, issue.1, pp.17-23, 2012.
DOI : 10.1016/j.jhep.2012.02.018